Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 149 results for "mgm institute of health sciences"

Schemes to Promote Health Research in the Country

The Indian Council of Medical Re (ICMR) with a network of 32 institutes works in the field of Medical Re in communicable and non-communicable diseases throughout the country. The Department of Health Re has also launched five schemes to promote ... Noodls, 1 week ago

47 images for mgm institute of health sciences

Social Dashboard, 1 day ago, 1 week ago
Association of American Medical Colleges, 1 week ago
NDTV, 1 week ago, 3 weeks ago, 4 weeks ago
I Stock Analyst, 2 weeks ago
Pagosa Springs Sun, 1 month ago
BusinessWeek, 1 month ago
Irish Independent, 1 month ago

Huge Growth Delivered in Very Small Packages: SeeThruEquity's Ajay Tandon and Brandon Primack

( Newswire) Institutional investors are, by and large, unable to own shares in companies with market valuations of less than $100 million, which means most sellside analysts don't write research on very small companies. The paradox: ...
 Digital Media Net1 month ago
Yahoo! Finance

Bristol-Myers Squibb Receives Accelerated Approval of Opdivo (nivolumab) from the U.S. Food and Drug …

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company ( BMY ) today announced that the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) injection, for intravenous use. Opdivo is a human programmed death receptor-1 ...
 Yahoo! Finance2 days ago Bristol-Myers Squibb Company Release: Study Comparing Opdivo (Nivolumab) To Chemotherapy In Treatment Na??ve Advanced Melanoma Patients Marks First PD-1 Immune Checkpoint Inhibitor To Demonstrate A Survival Benefit In A Phase 3 Trial  BioSpace1 month ago CheckMate-066 study comparing Opdivo to chemotherapy to treat patients with nave advanced melanoma meets primary endpoint  PharmaBiz1 month ago Study Comparing Opdivo (nivolumab) to Chemotherapy in Treatment Nave Advanced Melanoma Patients Marks First PD-1 Immune Checkpoint Inhibitor to Demonstrate a Survival Benefit in a Phase 3 Trial  CNBC1 month ago

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer [Gastrointestinal Cancer]

⇑, Shantan G. Reddy , Nathan Bahary , Hope E. Uronis , Darren Sigal , Allen L. Cohn , William R. Schelman , Joe Stephenson Jr , E. Gabriela Chiorean , Peter J. Rosen , Brian Ulrich , Tomislav Dragovich , Salvatore A. Del ...
 Journal of Clinical Oncology1 week ago
Tutorial Finder

National Litigation Firm Manion Gaynor & Manning Continues Expansion with Offices in Louisiana and Mississippi

PR Web Boston, MA (PRWEB) December 09, 2014 Manion Gaynor & Manning LLP (MG&M) today announced the continued expansion of its national litigation practice with the opening of new offices in New Orleans and Lake Charles, Louisiana, and Hattiesburg, ...
 Insurance News Net2 weeks ago

Practice-Changing Study in HIV-Related Lymphoma

SAN FRANCISCO ― Patients with HIV-related lymphoma should now be considered candidates for stem cell transplantation if need be, and the treatment does not need to be limited to certain centers, according experts commenting on the results of a ...
 General Medicine eJournal2 weeks ago
Seeking Alpha

TG Therapeutics: Upcoming Data At ASH Conference Could Double Share Price

Summary TGTX to report updated data sets at ASH from 3 clinical trials in various Lymphomas such as CLL, NHL, MCL and SLL. One such data set will be the 1st ever report of the combination of a BTK inhibitor and a PI3K-delta inhibitor in patients ...
 Seeking Alpha3 weeks ago

Celator® Pharmaceuticals Announces Data And Safety Monitoring Board Recommendation To Continue Phase …

EWING, N.J., Dec. 1, 2014 /PRNewswire/ -- Celator Pharmaceuticals, Inc. ( CPXX ), a biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer, today announced that ...
 Yahoo! Finance3 weeks ago Threshold announces encouraging interim data from Phase I/II glioblastoma trial  Individual.com4 weeks ago THLD: Threshold's Provides an Update on its Phase I/II Trial using TH-302 in Glioblastoma  Yahoo! Finance1 month ago Threshold Pharmaceuticals Announces Phase 1/2 Interim Data Signaling Activity of TH-302 Plus Bevacizumab (Avastin(R)) in Patients With Glioblastoma  Pettinga Financial Advisors1 month ago

American International College Offers MBA in Resort and Casino Management

PRWeb The new MBA in Resort and Casino Management offered at American International College (AIC) is representative of the College's responsiveness to regional economic opportunities. With the Casino bill remaining intact in the Commonwealth, AIC ...
 Wall Street Business Network4 weeks ago

Identified Hospital by States and UTS for Treatment of Ebola Virus Disease

List of hospitals earmarked by the State/Union Territories for treatment of Ebola Virus Disease Delhi November 25, 2014 Last Updated at 14:20 IST List of hospitals earmarked by the State/Union Territories for treatment of Ebola Virus Disease is ...
 Business Standard India4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less